Our lab has broad interests in modeling, understanding, and exploiting the impact of environmental factors on human cell metabolism, with a particular focus on hematological cancers and normal lymphocytes. We use an interdisciplinary approach to discover unforeseen biological (and pharmacological) phenomena in cell metabolism, cancer biology, and immunology that may have been overlooked or misinterpreted owing to the use of conventional in vitro (and perhaps even in vivo) model systems that poorly mimic physiologic conditions. Ultimately, we aim to translate our findings into new therapeutic opportunities.
Jason earned his B.S. in Chemical Engineering (2004) magna cum laude from Cornell University, and then completed his Ph.D. in Chemical Engineering (2010) from the University of Texas at Austin. Under the guidance of George Georgiou, Jason’s doctoral research focused on the development of new strategies to engineer therapeutic enzymes with reduced immunogenicity for cancer therapy, and was supported, in part, through a graduate fellowship awarded by the U.S. Department of Homeland Security. Jason then carried out his postdoctoral research in the laboratory of David M. Sabatini at the Whitehead Institute for Biomedical Research (MIT). There, he focused on designing new tools to better understand how environmental factors influence the metabolic regulation of cancer cells. His postdoctoral research was funded, in part, through fellowships awarded by both the American Cancer Society and the Koch Institute for Integrative Cancer Research at MIT, and was also later recognized with a Margaret and Herman Sokol Postdoctoral Award from the Whitehead Institute. In August 2018, Jason became a Metabolism Investigator at the Morgridge Institute for Research and an Assistant Professor in the Departments of Biochemistry and Biomedical Engineering at the University of Wisconsin-Madison.
BS, Cornell University
PhD, University of Texas at Austin
Postdoctoral, Whitehead Institute for Biomedical Research/MIT
Margaret and Herman Sokol Postdoctoral Award, Whitehead Institute for Biomedical Research – 2017
Koch Institute Ludwig Postdoctoral Fellowship – 2016-2017
American Cancer Society Postdoctoral Fellowship – 2011-2014
NIH F32 Ruth L. Kirschstein NRSA Postdoctoral Fellowship (declined) – 2011-2014
George J. Heuer, Jr. Endowed Graduate Fellowship, Univ. of Texas at Austin – 2008
U.S. Department of Homeland Security Graduate Fellowship – 2005-2008
NSF Graduate Fellowship Honorable Mention – 2004, 2005
Thrust 2000 Fellowship, Univ. of Texas at Austin 2004-2007
B.S. awarded, magna cum laude – 2004
William C. Hooey Scholarship, Cornell University – 2003
Tau Beta Pi Engineering Honor Society, Cornell University – 2003
Cornell Club of Boston Scholarship, Cornell University – 2002-2003
Stephen Phillips Memorial Scholarship – 2000-2003
- Kanarek N., Keys H.R., Cantor JR, Lewis C.A., Chan S.H., Kunchok T., Abu-Remaileh M., Freinkman E., Schweitzer L.D., Sabatini D.M. 2018. Histidine catabolism is a major determinant of methotrexate sensitivity. Nature 559(7715):632-636.
- Cantor JR, Abu-Remaileh M., Kanarek N., Freinkman E., Gao X., Louissaint A. Jr, Lewis C.A., Sabatini D.M. 2017. Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase. Cell 169(2):258-272.e17.
- Wolfson R.L., Chantranupong L., Saxton R.A., Shen K., Scaria S.M., Cantor JR, Sabatini D.M. 2016. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science (New York, N.Y.) 351(6268):43-8.
- Kim D., Fiske B.P., Birsoy K., Freinkman E., Kami K., Possemato R.L., Chudnovsky Y., Pacold M.E., Chen W.W., Cantor JR, Shelton L.M., Gui D.Y., Kwon M., Ramkissoon S.H., Ligon K.L., Kang S.W., Snuderl M., Vander Heiden M.G., Sabatini D.M. 2015. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520(7547):363-7.
- Shaul Y.D., Freinkman E., Comb W.C., Cantor JR, Tam W.L., Thiru P., Kim D., Kanarek N., Pacold M.E., Chen W.W., Bierie B., Possemato R., Reinhardt F., Weinberg R.A., Yaffe M.B., Sabatini D.M. 2014. Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 158(5):1094-1109.
- Paley O., Agnello G., Cantor J., Yoo T.H., Georgiou G., Stone E. 2013. GFP reporter screens for the engineering of amino acid degrading enzymes from libraries expressed in bacteria. Methods in molecular biology (Clifton, N.J.) 978:31-44.
- Li W., Cantor JR, Yogesha S.D., Yang S., Chantranupong L., Liu J.Q., Agnello G., Georgiou G., Stone E.M., Zhang Y. 2012. Uncoupling intramolecular processing and substrate hydrolysis in the N-terminal nucleophile hydrolase hASRGL1 by circular permutation. ACS chemical biology 7(11):1840-7.
- Cantor JR, Sabatini D.M. 2012. Cancer cell metabolism: one hallmark, many faces. Cancer discovery 2(10):881-98.
- Cantor JR, Panayiotou V., Agnello G., Georgiou G., Stone E.M. 2012. Engineering reduced-immunogenicity enzymes for amino acid depletion therapy in cancer. Methods in enzymology 502:291-319.
- Cantor JR, Yoo TH, Dixit A, Iverson BL, Forsthuber TG, Georgiou G. (2011) Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci U S A 108, 1272-1277